Acturum Life Science AB

  1. Home
  2. Customer cases
  3. Acturum Life Science AB

Acturum Life Science AB

Acturum Life Science AB

Acturum Life Science AB has taken over a large part of AstraZeneca patent portfolio, after the closure of AstraZeneca in Sodertalje.

Swea handles the around 20 patent families for Acturum. The management of this portfolio includes IP strategic discussions, license-related work, checks in scientific publications, and budgeting.

Contact us

+46 21 495 32 00

This email address is being protected from spambots. You need JavaScript enabled to view it.

Our offices

Kopparbergsvägen 6
SE-722 13 Västerås
(Sweden)

Forskargatan 20J
SE-151 36 Södertälje
(Sweden)

Storgatan 73
SE-852 30 Sundsvall
(Sweden)

We are a member of SEPAF

SepafSEPAF is an association of patent agencies in Sweden. Its purpose is to maintain high ethical and professional skills in the field. SEPAF’s general conditions offer customers security. The ethics committee ensures that ethical guidelines are followed, and any agency that violates the regulations is held accountable.